Clincosm LogoSign in Get a demo

relapsed cancer

Showing 1 - 18 of 18
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Refractory Cancer, Relapsed Cancer Trial in Weston (Drug Sensitivity Test (DST))

Not yet recruiting
  • Refractory Cancer
  • Relapsed Cancer
  • Drug Sensitivity Test (DST)
  • Weston, Florida
    Lerner College of Medicine: Cleveland Clinic Florida
Sep 1, 2023

Lymphoma, B-Cell, Relapsed Cancer, Refractory Lymphoma Trial in Boston (Adaptive Bridging Radiation Therapy (ABRT))

Not yet recruiting
  • Lymphoma, B-Cell
  • +7 more
  • Adaptive Bridging Radiation Therapy (ABRT)
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Aug 16, 2023

Relapsed Cancer, Refractory Multiple Myeloma, Multiple Myeloma Trial in Boston (Isatuximab, Belantamab mafodotin, Pomalidomide)

Not yet recruiting
  • Relapsed Cancer
  • +2 more
  • Boston, Massachusetts
  • +1 more
Jun 19, 2023

Large Cell Lymphoma, Diffuse, Relapsed Cancer, Refractory Cancer Trial (AutoSCT, GDP, Epcoritamab)

Not yet recruiting
  • Large Cell Lymphoma, Diffuse
  • +2 more
  • AutoSCT
  • +2 more
  • (no location specified)
May 10, 2023

Acute Myeloid Leukemia, Relapsed Cancer, Refractory Cancer Trial in Edmonton, Toronto (Enasidenib, Venetoclax)

Active, not recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Edmonton, Alberta, Canada
  • +1 more
Jan 31, 2023

Triple Negative Breast Cancer, TNBC - Triple-Negative Breast Cancer, NSCLC Trial in United States (LYL797)

Recruiting
  • Triple Negative Breast Cancer
  • +14 more
  • LYL797
  • Scottsdale, Arizona
  • +10 more
Jan 30, 2023

Precision Medicine for Every Child With Cancer

Recruiting
  • Childhood Cancer
  • +5 more
  • Whole Genome Sequencing
  • +6 more
  • Adelaide, Australia
  • +8 more
Jan 24, 2023

Non Small Cell Lung Cancer, Pancreatic Cancer, Colorectal Cancer Trial in United States (BMF-219)

Recruiting
  • Non Small Cell Lung Cancer
  • +16 more
  • Goodyear, Arizona
  • +10 more
Jan 24, 2023

Usability of Cellworks Singula™ and Cellworks Ventura™ Reports

Recruiting
  • Cancer
  • +2 more
  • Cellworks Report
  • Sioux Falls, South Dakota
    Avera Cancer Institute
Jan 20, 2023

Primary CNS Lymphoma, Secondary CNS Lymphoma, Relapsed Cancer Trial in Miami (drug, procedure, radiation)

Not yet recruiting
  • Primary Central Nervous System Lymphoma
  • +3 more
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc.
Dec 23, 2022

Solid Tumor, Adult, Relapsed Cancer, Refractory Cancer Trial (HST-1011, Cemiplimab)

Not yet recruiting
  • Solid Tumor, Adult
  • +2 more
  • (no location specified)
Dec 14, 2022

Multiple Myeloma, Relapsed Cancer, Refractory Multiple Myeloma Trial (ANV419, Lenalidomide with low-dose dexamethasone,

Not yet recruiting
  • Multiple Myeloma
  • +4 more
  • (no location specified)
Nov 29, 2022

Advanced Cancer, Relapsed Cancer, Refractory Cancer Trial in Nashville (Animal-Assisted Interactions)

Recruiting
  • Advanced Cancer
  • +2 more
  • Animal-Assisted Interactions
  • Nashville, Tennessee
    Monroe Carell Jr Children's Hospital at Vanderbilt
May 9, 2022

Cancer, Malignancy, Refractory Cancer Trial in Singapore (Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted ?d T

Not yet recruiting
  • Cancer
  • +3 more
  • Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells (CTM-N2D)
  • Singapore, Singapore
    National University Hospital
Mar 20, 2022

Advanced Cancer, Relapsed Cancer, Refractory Cancer Trial in Nashville (Animal-Assisted Interactions)

Active, not recruiting
  • Advanced Cancer
  • +2 more
  • Animal-Assisted Interactions
  • Nashville, Tennessee
    Monroe Carell Jr Children's Hospital at Vanderbilt
Jan 18, 2022

Classical Hodgkin Lymphoma, Relapsed Cancer, Refractory Cancer Trial in Toronto (Pembrolizumab, Bendamustine Hydrochloride)

Recruiting
  • Classical Hodgkin Lymphoma
  • +2 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Dec 31, 2021

PRecISion Medicine for Children With Cancer

Recruiting
  • Childhood Cancer
  • +5 more
  • Molecular profiling and drug testing
  • Newcastle, New South Wales, Australia
  • +7 more
Dec 5, 2021

Lung Cancer, Anaplastic Lymphoma Kinase Gene Translocation, ROS1 Rearrangement Trial in Boston (Lorlatinib, Crizotinib,

Recruiting
  • Lung Cancer
  • +6 more
  • Boston, Massachusetts
  • +1 more
Mar 7, 2021